Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Property:RefScope

From GxPlex

Jump to: navigation, search

Text

Applicable scope of this reference.

previous 202050100250500next 20
Showing 20 pages using this property.
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 10.3 +
HM  +
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 10.4 +
HM  +
E
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 51 +
HM  +
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 66 +
HM  +
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 67 +
HM  +
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 68 +
HM  +
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 69 +
HM  +
G
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 investigational medicinal product +
HM  +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 7 Part 2 2. +
HM  +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 12. +
HM  +
U
USA 21 CFR Part 312 09-Apr-2025 § 312.6 - §312.8 ; § 312.10 +
HM  +
USA 21 CFR Part 312 09-Apr-2025 § 312.40 (c) (d) +
HM  +
USA 21 CFR Part 312 09-Apr-2025 § 312.53 (b) +
HM  +
USA 21 CFR Part 312 09-Apr-2025 § 312.61 +
HM  +
USA 21 CFR Part 312 09-Apr-2025 § 312.62 (a) +
HM  +
USA 21 CFR Part 312 09-Apr-2025 § 312.69 +
HM  +
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.4 - Introduction +
HM  +
E
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 47-003 +
HM  +
G
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 6. +
HM  +
U
USA 21 CFR Part 312 09-Apr-2025 § 312.53 (c) (vi) - (vii) +
HM  +
Retrieved from "https://gxplex.org/index.php?title=Property:RefScope&oldid=6218"